Frontiers in New Drug Discovery From Molecular Targets to Preclinical Trials
The intention of this Special Issue is to focus on new aspects of drug discovery, including the search for new molecular targets of various diseases, the creation of new modern methods for diagnosing diseases, the development of new test systems and kits for assessing the selectivity and effectivene...
Saved in:
Other Authors: | |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_100841 | ||
005 | 20230623 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20230623s2023 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-0365-7682-4 | ||
020 | |a 9783036576831 | ||
020 | |a 9783036576824 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-0365-7682-4 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a GP |2 bicssc | |
072 | 7 | |a PS |2 bicssc | |
100 | 1 | |a Aminin, Dmitry |4 edt | |
700 | 1 | |a Aminin, Dmitry |4 oth | |
245 | 1 | 0 | |a Frontiers in New Drug Discovery |b From Molecular Targets to Preclinical Trials |
260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
300 | |a 1 electronic resource (236 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a The intention of this Special Issue is to focus on new aspects of drug discovery, including the search for new molecular targets of various diseases, the creation of new modern methods for diagnosing diseases, the development of new test systems and kits for assessing the selectivity and effectiveness of new drugs, the study of the molecular mechanisms of biologically active compounds, the formulation of new drugs, pharmacokinetic and pharmacodynamic studies, and preclinical trials of important molecules. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Research & information: general |2 bicssc | |
650 | 7 | |a Biology, life sciences |2 bicssc | |
653 | |a Streptococci | ||
653 | |a antimicrobials | ||
653 | |a QSAR | ||
653 | |a MD simulation | ||
653 | |a Kunitz-type peptides | ||
653 | |a neuroprotective activity | ||
653 | |a sea anemones | ||
653 | |a TRPV1 | ||
653 | |a P2X7R | ||
653 | |a Parkinson's disease (PD) | ||
653 | |a diffuse large B cell lymphoma (DLBCL) | ||
653 | |a deep neural network | ||
653 | |a drug discovery | ||
653 | |a drug combination | ||
653 | |a biomarker | ||
653 | |a cancer severity | ||
653 | |a cancer prognosis | ||
653 | |a MAFB | ||
653 | |a tumor-associated macrophages | ||
653 | |a prostate cancer | ||
653 | |a photodynamic therapy | ||
653 | |a magnetic resonance imaging | ||
653 | |a ex vivo | ||
653 | |a anti-inflammatory substance | ||
653 | |a N-acylhydrazone | ||
653 | |a naphthyl-N-acylhydrazone | ||
653 | |a LASSBio-1524 analogues | ||
653 | |a phosphacoumarin | ||
653 | |a azomethine ylide | ||
653 | |a cycloaddition | ||
653 | |a anti-cancer | ||
653 | |a cytotoxicity | ||
653 | |a quantum chemistry | ||
653 | |a pravastatin | ||
653 | |a metformin | ||
653 | |a radiation-induced intestinal injury | ||
653 | |a minipigs | ||
653 | |a epithelial regeneration | ||
653 | |a inflammation | ||
653 | |a arylazo sulfones | ||
653 | |a DNA binding | ||
653 | |a DNA cleavage | ||
653 | |a DNA photocleavage | ||
653 | |a A375 melanoma cells | ||
653 | |a molecular docking | ||
653 | |a radicals | ||
653 | |a N-S bond homolysis | ||
653 | |a platinum(II) | ||
653 | |a five-coordinate complexes | ||
653 | |a glycoconjugation | ||
653 | |a cytotoxic activity | ||
653 | |a protein X-ray structure | ||
653 | |a lipophilicity | ||
653 | |a natural products | ||
653 | |a acetylcholinesterase inhibitors | ||
653 | |a butyrylcholinesterase inhibitors | ||
653 | |a Alzheimer's disease | ||
653 | |a central nervous system | ||
653 | |a n/a | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/7304 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/100841 |7 0 |z DOAB: description of the publication |